Sanchez L, Nakama T, Nagai H, Matsuoka O, et al. Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults >/= 60 years of age: Results from a phase III, randomized clinical trial. Vaccine 2023 Mar 9:S0264-410X(23)00225-6. doi: 10.1016/j.vaccine.2023.
PMID: 36906404